Prescription medication, when used properly and safely, can provide needed relief to consumers suffering a wide range of illnesses or physical conditions. However, those medications must be marketed and advertised properly. That apparently wasn’t the case for a antipsychotic prescription drug manufactured Bristol-Myers Squibb (BMS). As a result, the company has agreed to pay $19.5 million in a settlement with 42 states and the District of Columbia. [More]
abilify
![KogeLiz](../../consumermediallc.files.wordpress.com/2016/12/screen-shot-2016-12-08-at-12-08-06-pm.png?w=300&h=225&crop=1)
Bristol-Myers Squibb Agrees To Pay $19.5M Over Improper Marketing Of Medication
By Updated: 12.12.16
12.8.16 —